CONTROLLED STUDY OF TWO COMPONENTS OF FERROUS POLYMOTHERAPY IN THE TREATMENT OF FERROPENIC ANEMIA IN CHILDREN FROM 6 MONTHS TO 2 YEARS OLD

Not Applicable

• Conditions: -D50 Iron deficiency anaemia; Iron deficiency anaemia; D50

• Registration Number: PER-040-04
• Lead Sponsor: ABL PHARMA PERU,

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2004-07-21
• Last Update Posted: 4 September 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. You must have the consent of informed consent.
2. Have an age between 6 months and 2 years.
3. Hemoglobin> 8 and <11 g / dl. and / or decreased serum Ferritin
4. Be able to attend the consultation according to the study schedule.
5. Be included between the 10-90 percentiles, age-statural for age and sex according to the NCHS tables.

Exclusion Criteria

1. History of intolerance to iron salts.
2. History of chronic anemia resistant to treatment.
3. Acute or chronic pathologies that can modify the blood values.
4. Intestinal parasitosis detected by simple direct examination at the time of onset
of the study.
5. Need to use medications that can modify the blood values.
6. History of blood discies.
7. History of liver or kidney pathology.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br>Outcome name:Ferritin levels<br>Measure:Ferritin levels achieved at twelve weeks in patients of both groups with pharyngeal polymodal<br>Timepoints:12 weeks<br>

Secondary Outcome Measures

Name	Time	Method
<br>Outcome name:Percentage of patients who are withdrawn from the study due to adverse reactions.<br>Measure:Percentage of patients who are withdrawn from the study due to adverse reactions.<br>Timepoints:12 weeks<br>